BEDROCK Act

Increased Supply Chain Resilience: By identifying vulnerabilities, chokepoints, and reliance on foreign adversaries for critical inputs, the bill aims to strengthen domestic production and diversify suppliers (Section 2(b)(1)(C) and 2(c)(1)(C)).

Easier Path to Market: The creation of a "Federal Commercialization Pathway Map" and a public web resource helps businesses navigate Federal processes, reducing duplication and unpredictability in getting products to market (Section 2(b)(4) and 2(e)(1)).

Support for Small Businesses: The bill specifically requires the Secretary to identify practices that help small and medium-sized businesses and manufacturers participate in biomanufacturing (Section 2(d)(1)(G)).

Improved Government Guidance: The designation of specific points of contact at the FDA and EPA provides non-Federal entities with direct assistance in finding information related to laws and processes (Section 2(e)(3)).

Protection of Intellectual Property: The bill establishes rules to ensure that trade secrets and confidential business information submitted to the government are not publicly disclosed (Section 2(f)(1)).

Reliance on Voluntary Participation: Many of the benefits, such as consultations and information sharing, are on a voluntary basis, which means the effectiveness of the program depends on whether private entities choose to participate (Section 2(b)(2) and 2(d)(1)(E)).

Limited Duration: The requirements for the Secretary to carry out most of these activities, including the assessments and the pathway map, terminate five years after the Act is enacted (Section 2(h)).